These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 8612318

  • 1. Phase I study of ifosfamide plus high-dose epirubicin in advanced non-small-cell lung cancer.
    Gridelli C, Rossi A, Incoronato P, Bruni GS, Scognamiglio F, Ruffolo P, Rinaldi L, Bianco AR.
    Cancer Chemother Pharmacol; 1996; 37(6):613-5. PubMed ID: 8612318
    [Abstract] [Full Text] [Related]

  • 2. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA, Hoffman PC, Drinkard LC, Watson S, Samuels BL, Golomb HM, Vokes EE.
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [Abstract] [Full Text] [Related]

  • 3. Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
    Hoffman PC, Masters GA, Drinkard LC, Krauss SA, Samuels BL, Golomb HM, Vokes EE.
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):11-5. PubMed ID: 8677441
    [Abstract] [Full Text] [Related]

  • 4. Ifosfamide-based chemotherapy for previously treated lung cancer patients.
    Chen YM, Liu JM, Wu MF, Wu HW, Lin WC, Tsai CM, Perng RP, Whang-Peng J.
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):389-96. PubMed ID: 9699391
    [Abstract] [Full Text] [Related]

  • 5. Phase I dose-escalation trial of paclitaxel and ifosfamide in patients with advanced non-small cell lung cancer.
    Shepherd FA, Latreille J, Paul K, Eisenhauer E.
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):84-90. PubMed ID: 9007130
    [Abstract] [Full Text] [Related]

  • 6. Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy.
    Huisman C, Biesma B, Postmus PE, Giaccone G, Schramel FM, Smit EF.
    Br J Cancer; 2001 Nov 16; 85(10):1456-61. PubMed ID: 11720428
    [Abstract] [Full Text] [Related]

  • 7. Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer.
    Hoffman PC, Krauss SA, Drinkard LC, Masters GA, Samuels BL, Bitran JD, Golomb HM, Watson S, Vokes EE.
    Semin Oncol; 1995 Aug 16; 22(4 Suppl 9):38-41. PubMed ID: 7544026
    [Abstract] [Full Text] [Related]

  • 8. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
    Brugger W, Frommhold H, Pressler K, Mertelsmann R, Kanz L.
    Semin Oncol; 1995 Feb 16; 22(1 Suppl 2):3-8. PubMed ID: 7531368
    [Abstract] [Full Text] [Related]

  • 9. Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancer.
    Gridelli C, De Placido S, Pepe R, Incoronato P, Airoma G, Rossi A, Palazzolo G, Bianco AR.
    Eur J Cancer; 1993 Feb 16; 29A(12):1729-31. PubMed ID: 7691117
    [Abstract] [Full Text] [Related]

  • 10. Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and Paclitaxel as first-line treatment.
    Yang CH, Chen MC, Cheng AL, Hsu CH, Yeh KH, Yu YC, Whang-Peng J, Yang PC.
    Oncology; 2005 Feb 16; 68(4-6):350-5. PubMed ID: 16020962
    [Abstract] [Full Text] [Related]

  • 11. Dose intensification--a phase I study of ifosfamide with vinorelbine (Navelbine): rationale and study design in advanced non-small cell lung cancer.
    Drinkard LC, Hoffman PC, Samuels BL, Watson S, Bitran JD, Golomb HM, Vokes EE.
    Semin Oncol; 1995 Apr 16; 22(2 Suppl 5):30-7; discussion 41-4. PubMed ID: 7537911
    [Abstract] [Full Text] [Related]

  • 12. Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial.
    Lorusso V, Gebbia V, Spada M, Guida M, Cassano G, Brunetti C, Germano D, Nettis G, Izzi G, Galetta D, Giampaglia M, Silvestris N, Colucci G.
    Oncol Rep; 2005 Dec 16; 14(6):1547-51. PubMed ID: 16273254
    [Abstract] [Full Text] [Related]

  • 13. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
    Strauss GM, Lynch TJ, Elias AD, Jacobs C, Kwiatkowski DJ, Shulman LN, Carey RW, Grossbard ML, Jauss S, Sugarbaker DJ.
    Semin Oncol; 1995 Aug 16; 22(4 Suppl 9):70-4. PubMed ID: 7544029
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic re-evaluation and phase I study of high dose epirubicin in advanced non-small cell lung cancer.
    Nishio M, Ohata M, Kobayashi H, Suruda T, Uetani K, Funasako M, Nishio K, Sasaki Y, Saijo N.
    Jpn J Clin Oncol; 1993 Oct 16; 23(5):284-90. PubMed ID: 8230753
    [Abstract] [Full Text] [Related]

  • 15. Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: experience of the European Lung Cancer Working Party.
    Sculier JP, Bureau G, Giner V, Thiriaux J, Michel J, Berchier MC, Van Cutsem O, Küstner U, Kroll F, Mommen P.
    Semin Oncol; 1995 Feb 16; 22(1 Suppl 2):18-22. PubMed ID: 7846537
    [Abstract] [Full Text] [Related]

  • 16. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
    Belli L, LeChevalier T, Gottfried M, Adams D, Ruffie P, LeCesne A, Tete L, Pellae-Cosset B.
    Semin Oncol; 1995 Dec 16; 22(6 Suppl 15):29-33. PubMed ID: 8643967
    [Abstract] [Full Text] [Related]

  • 17. Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas.
    Toma S, Palumbo R, Canavese G, Albanese E, Cantoni E, Barisone A, Reggiardo G, Rosso R, Santi L.
    Cancer Chemother Pharmacol; 1993 Dec 16; 31 Suppl 2():S222-7. PubMed ID: 8453703
    [Abstract] [Full Text] [Related]

  • 18. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Dec 16; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 19. Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer.
    Mantovani G, Macciò A, Mulas C, Massa E, Madeddu C, Mura L, Contu P, Versace R.
    Oncol Rep; 2002 Dec 16; 9(3):661-70. PubMed ID: 11956647
    [Abstract] [Full Text] [Related]

  • 20. European experience with ifosfamide in non-small cell lung cancer.
    Drings P.
    Semin Oncol; 1989 Feb 16; 16(1 Suppl 3):22-30. PubMed ID: 2539645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.